ROSENWALD LINDSAY A MD

CIK 000094184126 companiesBURLINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0000941841

Recent Transactions

50 trades

Award
Journey Medical Corp$DERM
Common Stock, $0.0001 par value
2025-08-05+50,000→ 211,146 total
Award
Journey Medical Corp$DERM
Common Stock, $0.0001 par value
2025-06-25+7,173→ 161,146 total
Disposition from Tender
Checkpoint Therapeutics, Inc.
COMMON STOCK
2025-05-30−207,007→ 0 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK
2025-05-29$1.29/sh+50,000→ 207,007 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK
2025-05-28+12,195→ 157,007 total
Award
Fortress Biotech, Inc.$FBIO
Common stock, par value $0.001
2025-01-01+454,153→ 4,111,417 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-12-13+12,638→ 144,812 total
Award
AVENUE THERAPEUTICS, INC.$ATXI
Employee stock option (right to buy)
2024-09-23+30,000→ 30,000 total
Purchase
Fortress Biotech, Inc.$FBIO
Warrants to Purchase Common Stock
2024-09-23$0.13/sh+763,359→ 763,359 total
Purchase
Fortress Biotech, Inc.$FBIO
Common stock, par value $0.001
2024-09-23$1.84/sh+763,359→ 3,657,264 total
Purchase
Fortress Biotech, Inc.$FBIO
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2024-07-11$7.48/sh+5,000→ 127,500 total
Purchase
Fortress Biotech, Inc.$FBIO
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2024-07-09$7.39/sh+5,000→ 122,500 total
Award
Journey Medical Corp$DERM
Common Stock, $0.0001 par value
2024-07-08+9,728→ 153,973 total
Purchase
Fortress Biotech, Inc.$FBIO
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2024-07-08$7.35/sh+5,000→ 117,500 total
Purchase
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2024-06-28$1.64/sh+20,000→ 2,893,905 total
Purchase
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2024-05-16$1.76/sh+10,000→ 2,873,905 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-05-14+32,051→ 82,174 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK
2024-05-14+50,000→ 132,174 total
Purchase
Journey Medical Corp$DERM
Common Stock, $0.0001 par value
2024-03-25$3.04/sh+10,000→ 144,245 total
Purchase
Journey Medical Corp$DERM
Common Stock, $0.0001 par value
2024-03-22$3.40/sh+20,000→ 134,245 total
Purchase
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2024-01-05$2.38/sh+50,000→ 2,863,905 total
Award
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2024-01-01+216,465→ 2,813,905 total
Purchase
Fortress Biotech, Inc.$FBIO
Warrants to purchase Common Stock
2023-11-14+1,567,515→ 1,567,515 total
Purchase
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2023-11-14$1.70/sh+1,567,515→ 2,597,440 total
Purchase
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2023-09-26$0.28/sh+100,000→ 15,449,091 total
Purchase
AVENUE THERAPEUTICS, INC.$ATXI
Common Stock
2023-09-08$0.72/sh+348,675→ 354,318 total
Purchase
Journey Medical Corp$DERM
Common Stock, par value $0.0001 per share
2023-09-06$2.23/sh+100,000→ 114,245 total
Purchase
Fortress Biotech, Inc.$FBIO
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2023-08-18$9.34/sh+10,000→ 112,500 total
Purchase
Fortress Biotech, Inc.$FBIO
SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK
2023-08-17$11.75/sh+10,000→ 102,500 total
Award
MUSTANG BIO, INC.$MBIO
COMMON STOCK, PAR VALUE $0.0001
2023-07-05+7,246→ 60,525 total
Award
AVENUE THERAPEUTICS, INC.$ATXI
Employee stock option (right to buy)
2023-06-30+100,000→ 100,000 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK
2023-06-13+17,483→ 50,123 total
Purchase
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2023-02-10$0.83/sh+2,395,209→ 15,349,091 total
Award
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2023-01-01+1,219,294→ 12,953,882 total
Purchase
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2022-12-01$0.68/sh+100,000→ 11,730,324 total
Purchase
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2022-11-30$0.56/sh+5,000→ 11,630,324 total
Purchase
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2022-10-21$0.69/sh+100,000→ 11,625,324 total
Purchase
MUSTANG BIO, INC.$MBIO
COMMON STOCK, PAR VALUE $0.0001
2022-09-13$0.52/sh+5,000→ 299,181 total
Award
MUSTANG BIO, INC.$MBIO
COMMON STOCK, PAR VALUE $0.0001
2022-07-29+71,664→ 294,181 total
Award
Journey Medical Corp$DERM
Common Stock, par value $0.0001 per share
2022-07-21+14,245→ 14,245 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK
2022-06-16+47,619→ 326,401 total
Award
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2022-06-01$0.73/sh+4,264→ 11,734,588 total
Purchase
MUSTANG BIO, INC.$MBIO
COMMON STOCK, PAR VALUE $0.0001
2022-03-18$0.74/sh+4,094→ 222,517 total
Award
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2022-01-01+1,102,986→ 11,525,324 total
Award
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2021-12-01$2.42/sh+1,250→ 10,422,338 total
Other
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2021-11-16+4,619→ 10,421,088 total
Other
Fortress Biotech, Inc.$FBIO
COMMON STOCK, PAR VALUE $0.001
2021-09-30+8,133→ 10,416,469 total
Award
MUSTANG BIO, INC.$MBIO
COMMON STOCK
2021-08-31$2.58/sh+1,170→ 218,423 total
Award
MUSTANG BIO, INC.$MBIO
COMMON STOCK
2021-06-28+13,774→ 217,253 total
Award
Checkpoint Therapeutics, Inc.
COMMON STOCK
2021-06-10+16,502→ 278,782 total

Companies

Recent Filings

Address

C/O CORONADO BIOSCIENCES, INC. 15 NEW ENGLAND EXECUTIVE PARK

BURLINGTON, MA, 01803

View on SEC.gov